Bi-specific antibodies, like a bridge between cancer and immune system


Monoclonal antibodies are specialized bullets that target only specific molecules. Some antibodies recognize proteins expressed by tumor cells, while others bind receptors on the surface of immune cells. What if they can do both? A class of antibody called BiTE (bi-specific T cell engager antibodies) is able to simultaneously bind a T cell and a cancer cell, forming a bridge between the two and thus helping the former destroy the latter.

Veterinary Immunotherapy and Translational Research


  • E-Mail:

    This email address is being protected from spambots. You need JavaScript enabled to view it.

  • Veterinary Immunotherapy and Translational Research
  • C.F. 97903190581


© Copyright 2020
Tutti i diritti riservati.